<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:24</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/3/1/24</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="131" segment_no="14" tag_type="text">Page 2 of 8</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="132" segment_no="15" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="60" height="10" font="font4" id="p1_t8" reading_order_no="5" segment_no="3" tag_type="title"><b>Background</b></text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">Fine needle aspiration cytology (FNAC) is a very helpful</text>
<text top="110" left="55" width="241" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">technique in diagnosis of benign and malignant lesions of</text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">lymp<a href="">h node [1-4</a>]. Many authors also claim that FNAC</text>
<text top="134" left="55" width="241" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">can accurately diagnose Hodgkin's and non-Hodgkin's</text>
<text top="145" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">lymphoma (NHL)[<a href="">5,6]. </a>However there is a wide variation</text>
<text top="157" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">of diagnostic sensitivity and specificity of FNAC in non-</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">Hodgkin's lymphoma <a href="">[5-8]. </a>The role of cytology in pri-</text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">mary diagnosis and sub-classification of non-Hodgkin's</text>
<text top="192" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">lymphoma is controversi<a href="">al [9</a>-<a href="">12</a>]. After the introduction</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">of REAL/WHO classification, there is much difference in</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text">the cytologist's approach of lymphoma diagnosis and</text>
<text top="228" left="55" width="241" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text">classification. WHO and REAL classification emphasized</text>
<text top="239" left="55" width="241" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="4" tag_type="text">immense importance on the cytomorphology and immu-</text>
<text top="251" left="55" width="241" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="text">nophenotype of lymphoma for accurate sub classification</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="4" tag_type="text"><a href="">[13,14]</a>. In this present study we have analyzed the role of</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="4" tag_type="text">flow cytometric immunotyping as an adjunct to FNAC for</text>
<text top="286" left="55" width="241" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="4" tag_type="text">diagnosis and sub-classification of NHL according to</text>
<text top="298" left="55" width="84" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="4" tag_type="text">WHO classification.</text>
<text top="322" left="55" width="115" height="10" font="font4" id="p1_t27" reading_order_no="24" segment_no="7" tag_type="title"><b>Materials and methods</b></text>
<text top="333" left="55" width="241" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="8" tag_type="text">This study is of five years duration from the year 2000 Jan-</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">uary to 2004 December. Only cases suggested or con-</text>
<text top="357" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">firmed as NHL by FNAC were selected. FNAC smears were</text>
<text top="369" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">prepared for May Grunwald Giemsa (MGG) and Haema-</text>
<text top="380" left="55" width="241" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">toxyline and Eosin stain in each case. The May Grunwald</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">Giemsa smears were studied immediately. A second pass</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">of the needle was done and material was collected in cit-</text>
<text top="416" left="55" width="241" height="9" font="font5" id="p1_t35" reading_order_no="32" segment_no="8" tag_type="text">rate buffer for flow cytometric immunophenotyping</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="8" tag_type="text">(FCI). The specimen was immediately processed and a</text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="8" tag_type="text">complete panel of antibodies was used for immunophe-</text>
<text top="451" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="8" tag_type="text">notyping. Both cytologic findings and FCI data were inter-</text>
<text top="463" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="8" tag_type="text">preted together to diagnose and sub-classify NHL</text>
<text top="474" left="55" width="241" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="8" tag_type="text">according to WHO classification as far as possible. Wher-</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t41" reading_order_no="38" segment_no="8" tag_type="text">ever possible the final histological diagnosis was corre-</text>
<text top="498" left="55" width="151" height="9" font="font5" id="p1_t42" reading_order_no="39" segment_no="8" tag_type="text">lated with FNAC and FCI diagnosis.</text>
<text top="522" left="55" width="93" height="9" font="font6" id="p1_t43" reading_order_no="40" segment_no="10" tag_type="title"><i><b>Specimen preparation</b></i></text>
<text top="533" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="11" tag_type="text">FNAC material was collected in citrate buffer solution and</text>
<text top="545" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="11" tag_type="text">immediately transferred to flow cytometry laboratory. The</text>
<text top="557" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="11" tag_type="text">sample was washed in phosphate buffer solution three</text>
<text top="568" left="55" width="241" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="11" tag_type="text">times for 5 minutes at 2000 revolutions per minute. The</text>
<text top="580" left="55" width="241" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="11" tag_type="text">supernatant fluid was discarded and the deposits of cells</text>
<text top="592" left="55" width="241" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="11" tag_type="text">were studied for cell viability and count. After that, the</text>
<text top="604" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="11" tag_type="text">suspension was divided into multiple tubes depending on</text>
<text top="615" left="55" width="241" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="11" tag_type="text">the adequacy of the cell. Samples were then incubated for</text>
<text top="627" left="55" width="113" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="11" tag_type="text">15 minutes in dark with 5 </text>
<text top="624" left="168" width="6" height="12" font="font7" id="p1_t53" reading_order_no="50" segment_no="11" tag_type="text">μ</text>
<text top="627" left="174" width="122" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="11" tag_type="text">l of antibody solution tagged</text>
<text top="639" left="55" width="241" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="11" tag_type="text">with Fluorescein isothyocyanate (FITC) or Phycoerythrin</text>
<text top="651" left="55" width="241" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="11" tag_type="text">(PE). The following antibodies were used: CD3, CD2, CD</text>
<text top="662" left="55" width="236" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="11" tag_type="text">4, CD5, CD8, CD7, CD10, CD19, CD20, CD23, CD45, </text>
<text top="660" left="291" width="5" height="12" font="font7" id="p1_t58" reading_order_no="55" segment_no="11" tag_type="text">κ</text>
<text top="674" left="55" width="19" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="11" tag_type="text">and </text>
<text top="671" left="73" width="5" height="12" font="font7" id="p1_t60" reading_order_no="57" segment_no="11" tag_type="text">λ</text>
<text top="674" left="79" width="217" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="11" tag_type="text">. (Becton Dicikinson, San Jose, CA, USA). After incu-</text>
<text top="686" left="55" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="11" tag_type="text">bation, red blood cells were lysed by a lysing solution</text>
<text top="698" left="55" width="241" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="11" tag_type="text">(Becton Dicikinson, USA, Catalogue no 349202) for 15</text>
<text top="709" left="55" width="241" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="11" tag_type="text">minutes and then washed by a cell wash solution (Becton</text>
<text top="721" left="55" width="241" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="11" tag_type="text">Dicikinson, USA, Catalogue no 349524). After centrifug-</text>
<text top="87" left="313" width="233" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="2" tag_type="text">ing, the supernatant solution was discarded and 500 </text>
<text top="84" left="546" width="6" height="12" font="font7" id="p1_t67" reading_order_no="64" segment_no="2" tag_type="text">μ</text>
<text top="87" left="551" width="3" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="2" tag_type="text">l</text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="2" tag_type="text">cell fixative was added (Becton Dicikinson, Catalogue no</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="2" tag_type="text">340181). Flow cytometry analysis was then performed in</text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t71" reading_order_no="68" segment_no="2" tag_type="text">Becton Dicikinson flow cytometer (San Jose, CA, USA) by</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="2" tag_type="text">dual-color analysis technique. Gating was done using for-</text>
<text top="145" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="2" tag_type="text">ward and side scatter and also by the help of Cell Quest</text>
<text top="157" left="313" width="241" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="2" tag_type="text">software (San Jose, CA, USA). We analyzed a minimum</text>
<text top="169" left="313" width="194" height="9" font="font5" id="p1_t75" reading_order_no="72" segment_no="2" tag_type="text">number of 10,000 events for each cell marker.</text>
<text top="193" left="313" width="36" height="10" font="font4" id="p1_t76" reading_order_no="73" segment_no="5" tag_type="title"><b>Results</b></text>
<text top="204" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="6" tag_type="text">There were total 48 cases included in this study and in all</text>
<text top="216" left="313" width="241" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="text">these cases FNAC confirmed or suggested the diagnosis of</text>
<text top="228" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="6" tag_type="text">NHL. Age of the patients ranged from 6 year to 78 years.</text>
<text top="239" left="313" width="241" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="6" tag_type="text">There were 34 male and 14 female patients. Twenty-nine</text>
<text top="251" left="313" width="241" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="6" tag_type="text">cases were first time investigated in our FNAC clinic for</text>
<text top="263" left="313" width="241" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="6" tag_type="text">primary diagnosis and 19 cases were recurrent NHL. In 36</text>
<text top="275" left="313" width="241" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="6" tag_type="text">cases, the masses were palpable and FNAC was done with-</text>
<text top="286" left="313" width="241" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="6" tag_type="text">out any radiological guidance (table<a href=""> 1). In 12 c</a>ases masses</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="6" tag_type="text">were non-palpable and FNAC was done with the help of</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="6" tag_type="text">Ultrasonographic guidance. FNAC yielded adequate</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="6" tag_type="text">material in all these deep-seated cases. The cases were clas-</text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="6" tag_type="text">sified on FNAC as predominant small cells (12), mixed</text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="6" tag_type="text">small and large cells (5) and large cells (26) [table <a href="">2]. In</a></text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="6" tag_type="text">five cases a suggestion of NHL was offered on FNAC mate-</text>
<text top="369" left="313" width="241" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="6" tag_type="text">rial and these cases were labeled as NHL not otherwise</text>
<text top="380" left="313" width="241" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="6" tag_type="text">specified (NHL-NOS). Flow cytometry could be per-</text>
<text top="392" left="313" width="241" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="6" tag_type="text">formed in 45 cases (93.8%) and in rest of the three cases</text>
<text top="404" left="313" width="241" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="6" tag_type="text">the material was inadequate because of scanty blood</text>
<text top="416" left="313" width="241" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="6" tag_type="text">mixed aspirate. There were total 40 cases of B-NHL. These</text>
<text top="427" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="6" tag_type="text">cases showed predominant CD19 and CD20 positive cell</text>
<text top="439" left="313" width="241" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="6" tag_type="text">population. Light chain restriction (f<a href="">igure 1) c</a>ould be</text>
<text top="451" left="313" width="241" height="9" font="font5" id="p1_t98" reading_order_no="95" segment_no="6" tag_type="text">demonstrated in 30 out of 40 cases of B-NHL (75%).</text>
<text top="463" left="313" width="116" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="6" tag_type="text">There were 15 each cases of </text>
<text top="460" left="429" width="5" height="12" font="font7" id="p1_t100" reading_order_no="97" segment_no="6" tag_type="text">κ</text>
<text top="463" left="434" width="20" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="6" tag_type="text"> and </text>
<text top="460" left="455" width="5" height="12" font="font7" id="p1_t102" reading_order_no="99" segment_no="6" tag_type="text">λ</text>
<text top="463" left="460" width="94" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="6" tag_type="text"> light chain restriction.</text>
<text top="474" left="313" width="241" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="6" tag_type="text">In 10 cases there was no demonstrable light chain restric-</text>
<text top="486" left="313" width="241" height="9" font="font5" id="p1_t105" reading_order_no="102" segment_no="6" tag_type="text">tion on FCI. However cytology smears and predominant</text>
<text top="498" left="313" width="241" height="9" font="font5" id="p1_t106" reading_order_no="103" segment_no="6" tag_type="text">population of CD19 cells indicated a NHL of B cell origin.</text>
<text top="521" left="313" width="241" height="9" font="font5" id="p1_t107" reading_order_no="104" segment_no="9" tag_type="text">The diagnostic distribution of cases on the basis of FCI is</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t108" reading_order_no="105" segment_no="9" tag_type="text">highlighted in tabl<a href="">e 2. With</a> the help of combined FCI and</text>
<text top="561" left="313" width="188" height="7" font="font8" id="p1_t109" reading_order_no="106" segment_no="12" tag_type="title"><b>Table 1: Anatomic distribution of aspirated lesions</b></text>
<text top="579" left="317" width="19" height="7" font="font8" id="p1_t110" reading_order_no="107" segment_no="13" tag_type="table"><b>Sites</b></text>
<text top="579" left="448" width="76" height="7" font="font8" id="p1_t111" reading_order_no="108" segment_no="13" tag_type="table"><b>Number of patients</b></text>
<text top="601" left="317" width="27" height="7" font="font9" id="p1_t112" reading_order_no="109" segment_no="13" tag_type="table">Palpable</text>
<text top="612" left="317" width="69" height="7" font="font9" id="p1_t113" reading_order_no="110" segment_no="13" tag_type="table">Cervical lymph node</text>
<text top="612" left="448" width="8" height="7" font="font9" id="p1_t114" reading_order_no="111" segment_no="13" tag_type="table">19</text>
<text top="622" left="317" width="66" height="7" font="font9" id="p1_t115" reading_order_no="112" segment_no="13" tag_type="table">Inguinal lymph node</text>
<text top="622" left="448" width="4" height="7" font="font9" id="p1_t116" reading_order_no="113" segment_no="13" tag_type="table">3</text>
<text top="632" left="317" width="67" height="7" font="font9" id="p1_t117" reading_order_no="114" segment_no="13" tag_type="table">Axillary lymph node</text>
<text top="632" left="448" width="4" height="7" font="font9" id="p1_t118" reading_order_no="115" segment_no="13" tag_type="table">8</text>
<text top="642" left="317" width="90" height="7" font="font9" id="p1_t119" reading_order_no="116" segment_no="13" tag_type="table">Submandibular lymph node</text>
<text top="642" left="448" width="4" height="7" font="font9" id="p1_t120" reading_order_no="117" segment_no="13" tag_type="table">3</text>
<text top="653" left="317" width="91" height="7" font="font9" id="p1_t121" reading_order_no="118" segment_no="13" tag_type="table">Supraclavicular lymph node</text>
<text top="653" left="448" width="4" height="7" font="font9" id="p1_t122" reading_order_no="119" segment_no="13" tag_type="table">2</text>
<text top="663" left="317" width="14" height="7" font="font9" id="p1_t123" reading_order_no="120" segment_no="13" tag_type="table">Skin</text>
<text top="663" left="448" width="4" height="7" font="font9" id="p1_t124" reading_order_no="121" segment_no="13" tag_type="table">1</text>
<text top="673" left="317" width="77" height="7" font="font9" id="p1_t125" reading_order_no="122" segment_no="13" tag_type="table">Ultra Sonogram guided</text>
<text top="683" left="317" width="77" height="7" font="font9" id="p1_t126" reading_order_no="123" segment_no="13" tag_type="table">Abdominal lymph node</text>
<text top="683" left="448" width="4" height="7" font="font9" id="p1_t127" reading_order_no="124" segment_no="13" tag_type="table">6</text>
<text top="694" left="317" width="36" height="7" font="font9" id="p1_t128" reading_order_no="125" segment_no="13" tag_type="table">Bowel wall</text>
<text top="694" left="448" width="4" height="7" font="font9" id="p1_t129" reading_order_no="126" segment_no="13" tag_type="table">2</text>
<text top="704" left="317" width="42" height="7" font="font9" id="p1_t130" reading_order_no="127" segment_no="13" tag_type="table">Mediastinum</text>
<text top="704" left="448" width="4" height="7" font="font9" id="p1_t131" reading_order_no="128" segment_no="13" tag_type="table">3</text>
<text top="714" left="317" width="20" height="7" font="font9" id="p1_t132" reading_order_no="129" segment_no="13" tag_type="table">Testis</text>
<text top="714" left="448" width="4" height="7" font="font9" id="p1_t133" reading_order_no="130" segment_no="13" tag_type="table">1</text>
</page>
</pdf2xml>
